Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships
- 1 December 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 125 (7) , 1485-1490
- https://doi.org/10.1038/sj.bjp.0702226
Abstract
The present study describes the labelling of the nociceptin (NC) receptor, ORL1, in mouse forebrain membranes with a new ligand partially protected from metabolic degradation at the C‐terminal; the ligand, [3H]‐NC‐NH2, has a specific activity of 24.5 Ci mmol−1 Saturation experiments revealed a single class of binding sites with a KD value of 0.55 nm and Bmax of 94 fmol mg−1 of protein. Non specific binding was 30% of total binding. Kinetic binding studies yielded the following rate constants: Kobs=0.104 min−1; K1=0.034 min−1; T1/2=20 min; K+1=0.07 min nm−1. Thermodynamic analyses indicated that [3H]‐NC‐NH2 binding to the mouse ORL1 is totally entropy driven, similar to what has been observed for the labelled agonists to the opioid receptors OP1(δ), OP2(κ) and OP3(μ). Receptor affinities of several NC fragments and analogues, including the newly discovered ORL‐1 receptor antagonist [Phe1ψ(CH2‐NH)Gly2]NC(1–13)‐NH2 ([F/G]NC(1–13)‐NH2), were also evaluated in displacement experiments. The competition curves for these compounds were found to be parallel to that of NC and the following order of potency was determined for NC fragments: NC‐OH=NC‐NH2=NC(1–13)‐NH2 >> NC(1–12)‐NH2 > NC(1–13)‐OH >> NC(1–11)‐NH2, and for NC and NC(1–13)‐NH2 analogues: [Tyr1]NC‐NH2 [Leu1]NC(1–13)‐NH2 [Tyr1]NC(1–13)‐NH2 [F/G]NC(1–13)‐NH2 >> [Phe3]NC(1–13)‐NH2 > [DF/G]NC(1–13)‐NH2. Standard opioid receptor ligands (either agonists or antagonists) were unable to displace [3H]‐NC‐NH2 binding when applied at concentrations up to 10 μm indicating that this new radioligand interacts with a non opioid site, probably the ORL1 receptor. British Journal of Pharmacology (1998) 125, 1485–1490; doi:10.1038/sj.bjp.0702226Keywords
This publication has 30 references indexed in Scilit:
- Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assayBritish Journal of Pharmacology, 1998
- Structure−Activity Study of the Nociceptin(1−13)-NH2N-Terminal Tetrapeptide and Discovery of a Nociceptin Receptor AntagonistJournal of Medicinal Chemistry, 1998
- Relationship between binding affinity and functional activity of nociceptin/orphanin FQNeuropeptides, 1997
- Pharmacological characterization of nociceptin receptor: an in vitro studyCanadian Journal of Physiology and Pharmacology, 1997
- Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioidsEuropean Journal of Pharmacology, 1997
- The mouse vas deferens: a pharmacological preparation sensitive to nociceptinEuropean Journal of Pharmacology, 1996
- Determination of activity for nociceptin in the mouse vas deferensEuropean Journal of Pharmacology, 1996
- Temperature dependence of the binding of μ, δ and κ agonists to the opiate receptors in guinea-pig brainEuropean Journal of Pharmacology, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973